LR 19156
Alternative Names: LR-19156Latest Information Update: 06 Jun 2024
At a glance
- Originator LG Chem
- Class Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Obesity
Most Recent Events
- 12 Apr 2024 LR 19156 is available for licensing as of 12 Apr 2024. chat.openai.com/c/f1d95f34-1003-47dd-8bb1-1dce6c43f231
- 12 Apr 2024 Preclinical trials in Obesity in South Korea (unspecified route) (LG Chem Pipeline, April 2024)